GLP-1 RAs and SGLT2-Is to Lower Glucose and Reduce the Risk of Cardiovascular and Diabetic Kidney Disease

Leigh Morrison, Jonathan Gabison, Lauren Oshman

The Journal of the American Board of Family Medicine May 2024, 37 (3) 372-382; DOI: 10.3122/jabfm.2023.230455R1